MOB vs. APDN, JCSE, CRKN, MWG, SPCB, GWAV, AWX, VIEW, HIHO, and WATT
Should you be buying Mobilicom stock or one of its competitors? The main competitors of Mobilicom include Applied DNA Sciences (APDN), JE Cleantech (JCSE), Crown ElectroKinetics (CRKN), Multi Ways (MWG), SuperCom (SPCB), Greenwave Technology Solutions (GWAV), Avalon (AWX), View (VIEW), Highway (HIHO), and Energous (WATT). These companies are all part of the "industrial products" sector.
Applied DNA Sciences (NASDAQ:APDN) and Mobilicom (NASDAQ:MOB) are both small-cap industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, community ranking, profitability, analyst recommendations, valuation and dividends.
Mobilicom has a net margin of 0.00% compared to Mobilicom's net margin of -80.14%. Applied DNA Sciences' return on equity of 0.00% beat Mobilicom's return on equity.
Applied DNA Sciences received 290 more outperform votes than Mobilicom when rated by MarketBeat users. However, 100.00% of users gave Mobilicom an outperform vote while only 59.51% of users gave Applied DNA Sciences an outperform vote.
Applied DNA Sciences currently has a consensus target price of $1.50, suggesting a potential upside of 417.24%. Given Mobilicom's higher probable upside, research analysts plainly believe Applied DNA Sciences is more favorable than Mobilicom.
In the previous week, Mobilicom had 1 more articles in the media than Applied DNA Sciences. MarketBeat recorded 3 mentions for Mobilicom and 2 mentions for Applied DNA Sciences. Applied DNA Sciences' average media sentiment score of -0.21 beat Mobilicom's score of -0.67 indicating that Mobilicom is being referred to more favorably in the news media.
Mobilicom has lower revenue, but higher earnings than Applied DNA Sciences.
22.2% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 13.6% of Mobilicom shares are owned by institutional investors. 10.3% of Applied DNA Sciences shares are owned by insiders. Comparatively, 7.2% of Mobilicom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Applied DNA Sciences has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, Mobilicom has a beta of 2.42, indicating that its share price is 142% more volatile than the S&P 500.
Summary
Mobilicom beats Applied DNA Sciences on 9 of the 15 factors compared between the two stocks.
Get Mobilicom News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mobilicom Competitors List
Related Companies and Tools
